Hcv Recombinant Antigen

INTENDED USE The HCV Gold Rapid Screen Test (RST) is a Chromatographic immunoassay (CIA) for direct qualitative detection of antibodies to Hepatitis C type virus (HCV) in human serum/ plasma and whole blood. PRINCIPLE HCV RST is a chromatographic immunoassay (CIA) for the detection of antibodies to HCV in human serum/plasma and whole blood. HCV recombinant antigens are precoated onto membrane as a capture reagent on the test region. During the test, specimen is allowed to react with the colloidal gold particles, which have been labeled with HCV recombinant antigens. If antibodies to HCV present, a pink colored band will develop on the membrane in proportion to the amount of HCV antibodies present in the specimen .Absence of this pink colored band in the test region suggests a negative result. To serve as a procedural control, a purple colored band in the control region will always appear regardless the presence of antibodies to HCV. REAGENTS AND MATERIALS PROVIDED 1. One pouched cassette with desiccant. 2. Blood diluent in a dropper bottle, stored at 4-30°C. 3. One piece of operating instruction. WARNING AND PRECAUTIONS 1. For in vitro diagnostic uses only. 2. All patient samples should be treated as if capable of transmitting diseases. 3. Do not interchange reagents from different lots or use test kit beyond expiration date. 4. Icteric, lipemic, hemolysed, heat treated and contaminated sera may cause erroneous results. STORAGE The kits should be stored at temperature 4-30°C, the sealed pouch for the duration of the shelf life (24 months).

INTENDED USE The HCV Gold Rapid Screen Test (RST) is a Chromatographic immunoassay (CIA) for direct qualitative detection of antibodies to Hepatitis C type virus (HCV) in human serum/ plasma and whole blood. PRINCIPLE HCV RST is a chromatographic immunoassay (CIA) for the detection of antibodies to HCV in human serum/plasma and whole blood. HCV recombinant antigens are precoated onto membrane as a capture reagent on the test region. During the test, specimen is allowed to react with the colloidal gold particles, which have been labeled with HCV recombinant antigens. If antibodies to HCV present, a pink colored band will develop on the membrane in proportion to the amount of HCV antibodies present in the specimen .Absence of this pink colored band in the test region suggests a negative result. To serve as a procedural control, a purple colored band in the control region will always appear regardless the presence of antibodies to HCV. REAGENTS AND MATERIALS PROVIDED 1. One pouched cassette with desiccant. 2. Blood diluent in a dropper bottle, stored at 4-30°C. 3. One piece of operating instruction. WARNING AND PRECAUTIONS 1. For in vitro diagnostic uses only. 2. All patient samples should be treated as if capable of transmitting diseases. 3. Do not interchange reagents from different lots or use test kit beyond expiration date. 4. Icteric, lipemic, hemolysed, heat treated and contaminated sera may cause erroneous results. STORAGE The kits should be stored at temperature 4-30°C, the sealed pouch for the duration of the shelf life (24 months).

INTENDED USE The HCV Gold Rapid Screen Test (RST) is a Chromatographic immunoassay (CIA) for direct qualitative detection of antibodies to Hepatitis C type virus (HCV) in human serum/ plasma and whole blood. PRINCIPLE HCV RST is a chromatographic immunoassay (CIA) for the detection of antibodies to HCV in human serum/plasma and whole blood. HCV recombinant antigens are precoated onto membrane as a capture reagent on the test region. During the test, specimen is allowed to react with the colloidal gold particles, which have been labeled with HCV recombinant antigens. If antibodies to HCV present, a pink colored band will develop on the membrane in proportion to the amount of HCV antibodies present in the specimen .Absence of this pink colored band in the test region suggests a negative result. To serve as a procedural control, a purple colored band in the control region will always appear regardless the presence of antibodies to HCV. REAGENTS AND MATERIALS PROVIDED 1. One pouched cassette with desiccant. 2. Blood diluent in a dropper bottle, stored at 4-30°C. 3. One piece of operating instruction. WARNING AND PRECAUTIONS 1. For in vitro diagnostic uses only. 2. All patient samples should be treated as if capable of transmitting diseases. 3. Do not interchange reagents from different lots or use test kit beyond expiration date. 4. Icteric, lipemic, hemolysed, heat treated and contaminated sera may cause erroneous results. STORAGE The kits should be stored at temperature 4-30°C, the sealed pouch for the duration of the shelf life (24 months).

Product Details: Number of Reactions(Preps)/Kit 96 Wells Brand CTK BioTech Sample serum or plasma Storage 2 - 8 C Cat No : AE0510 INTENDED USE: The TRUSTwell HCV IgG ELISA Kit is a solid phase enzyme linked immunosorbent assay for the qualitative detection of IgG to Hepatitis C virus (HCV) in human serum or plasma. It is intended for professional use only as an aid in the diagnosis of infection with HCV. Any reactive specimen with the TRUSTwell HCV IgG ELISA Kit must be confirmed with alternative testing method(s) and clinical findings. TEST PRINCIPLE: The TRUSTwell HCV IgG ELISA Kit is a solid phase enzyme linked immunosorbent assay based on the principle of the indirect EIA technique for the detection of the IgG to HCV in human serum or plasma. The TRUSTwell HCV IgG ELISA Kit is composed of two key components: 1) Solid microwells pre-coated with recombinant HCV antigens; 2) Liquid conjugates composed of mouse anti-human IgG conjugated with horse radish peroxidase (HRP-anti Human IgG conjugates). During the assay, the test specimen is first incubated with the coated microwells. The IgG anti HCV, if present in the specimen, bind to the antigens coated on the microwell surface. In the second incubation with the HRP-anti-human IgG conjugates, the IgG antibodies absorbed on the surface of microwell react to the HRP-anti-human IgG conjugates. Unbounded conjugates are then removed by washing. The presence of the complexed conjugates is shown by a blue color upon additional incubation with TMB substrate. The reaction is stopped with Stop Solution and absorbances are read using a spectrophotometer at 450 /620-690 nm. Clinical Performance: A total of 1108 patient specimens from susceptible subjects were tested by the TRUSTwell HCV IgG ELISA Kit. Relative Sensitivity:100%, Relative Specificity:99.81%, Overall Agreement:99.82%.

HIV Antigen/antibody for ELISA recombinant antigen HIV-1 gp41+gp120 HIV-1 gp41 HIV-2 gp36 HIV-1+2 gp41+gp120+gp36 HIV-1 P24 HIV-1 gp41+gp120-HRP conjugate HIV-2 gp36-HRP conjugate antibody Monoclonal Anti-HIV P24 Polyclonal Anti-HIV P24 Biotin HIV Antigen/antibody for Rapid test recombinant antigen HIV-1 gp41+120 HIV-2 gp36 HIV-1+2 gp41+36+120 antibody Monoclonal Anti-HIV P24 Polyclonal Anti-HIV P24 Fapon Biotech provide gene engineering recombinant antigens and antibodys of HIV type 1¿¬¿«2 and group O, which can be used in ELISA and Rapid Test Kit, with high sensitive specific and stability.

General Information One-Step HCV Rapid Test is to detect the antibodies to HCV in human serum, plasma or whole blood. Applied highly purified recombinant proteins : Core,NS3,NS4,NS5 Method; Double Antigens Sandwich Method, the 4th generation Rapid Tests Sensitivity : 100%, Specificity : 100% Specimen : Serum, Plasma or Whole Blood Reading Time : 10 min.

Supplier: Rapid antigen test kits , viral transport media ( moh approved vtm kits), rna extraction kits , cr plates and machines. biochemistry analyser , biochemistry medias fda approved rapid test kits hiv , hcv , filter tips, laboratory consumables , agar plates , wolf air mask (the only device globally to be tested and effective 99.9 percent against covid 19)
Services: Export

The Chagas Ab Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of IgG anti-Trypanosoma cruzi (T. cruzi) in human serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with T. cruzi. Any reactive specimen with the Chagas Ab Rapid Test must be confirmed with alternative testing method(s) and clinical findings. Chagas disease is an insect-borne, zoonotic infection by the protozoan T. cruzi, which causes a systemic infection of humans with acute manifestations and long term sequelae. It is estimated that 16-18 million individuals are infected worldwide, and roughly 50,000 people die each year from chronic Chagas disease (World Health Organization)1. Buffy coat examination and xenodiagnosis used to be the most commonly methods2,3 in the diagnosis of acute T. cruzi infection. However, both methods are either time consuming or lack of sensitivity. Recently, serological test becomes the mainstay in the diagnosis of Chagasâ??s disease. In particularly, recombinant antigen based tests eliminate false-positive reactions which are commonly seen in the native antigen tests4-5. The Chagas Ab Rapid Test is an instant antibody test which detects IgG antibodies the T. cruzi within 15 minutes without any instrument requirements. By utilizing T. cruzi specific recombinant antigen, the test is highly sensitive and specific.

Innolab200600002PS-Semi-Auto Biochemistry Analyzer